{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e", "3T", 401104374, "LINCOLN PARK GROUP L.L.C.", 201628, "PD FRAZER CONSULTING, INC. ON BEHALF OF CANADA INTERNATIONAL PHARMACY ASSOC.", 2018, "third_quarter", "2018-08-03T09:48:36.853000-04:00", null, 0, 0, 1, "{\"url\": \"https://lda.senate.gov/api/v1/filings/1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e/\", \"filing_uuid\": \"1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e\", \"filing_type\": \"3T\", \"filing_type_display\": \"3rd Quarter - Termination\", \"filing_year\": 2018, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Reilly O'Connor\", \"dt_posted\": \"2018-08-03T09:48:36.853000-04:00\", \"termination_date\": \"2018-07-31\", \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"257A 14th Street SE\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Washington\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20003\", \"registrant\": {\"id\": 401104374, \"url\": \"https://lda.senate.gov/api/v1/registrants/401104374/\", \"house_registrant_id\": null, \"name\": \"LINCOLN PARK GROUP L.L.C.\", \"description\": \"Consulting and government affairs\", \"address_1\": \"3212 17th Street NE\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20018\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"REILLY O'CONNOR\", \"contact_telephone\": \"+1 202-384-4442\", \"dt_updated\": \"2026-01-26T13:09:21.978480-05:00\"}, \"client\": {\"id\": 201628, \"url\": \"https://lda.senate.gov/api/v1/clients/201628/\", \"client_id\": 48, \"name\": \"PD FRAZER CONSULTING, INC. ON BEHALF OF CANADA INTERNATIONAL PHARMACY ASSOC.\", \"general_description\": \"Government relations and international affairs\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2018-05-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"PHA\", \"general_issue_code_display\": \"Pharmacy\", \"description\": \"Support intent of H.R.1480 Safe and Affordable Drugs from Canada Act of 2017 Support intent of S.92 Safe and Affordable Drugs from Canada Act of 2017 Support intent of H.R. Affordable and Safe Prescription Drug Importation Act Support of S.469 Affordable and Safe Prescription Drug Importation Act; HR 5752 Stop Illicit Drug Importation Act.\", \"foreign_entity_issues\": \"Canada International Pharmacy Assoc. is a foreign entity.\", \"lobbyists\": [{\"lobbyist\": {\"id\": 65609, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"REILLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"O'CONNOR\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "DC", "US", null, "DC", "DC", "US", "US", "Government relations and international affairs", 0, 0, null, null, null, null]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["1fb42e2c-d26a-4f0d-93c6-6502f2a71a9e"], "units": {}, "query_ms": 0.7397839799523354, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}